Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TPSTTempest Therapeutics, Inc.

Nasdaq · CIK 0001544227
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts442

Identity from submissions API

NameTempest Therapeutics, Inc.
CIK0001544227
TickersTPST
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN451472564
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-798-8589
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Millendo Therapeutics, Inc. (2018-11-15T00:00:00.000Z → 2021-07-01T00:00:00.000Z)
  • OvaScience, Inc. (2012-04-09T00:00:00.000Z → 2018-12-06T00:00:00.000Z)
Business address
2000 SIERRA POINT PARKWAY
SUITE 400
BRISBANE
CA
94005
CA
Mailing address
2000 SIERRA POINT PARKWAY
SUITE 400
BRISBANE
CA
94005
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1061 filing rows loaded from submissions recent; extra archives: CIK0001544227-submissions-001.json (60 filings, 2012-04-09 to 2013-02-12).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 8-K CURRENT REPORT 3.01 0001213900-26-122694 001-35890 261579259 34 245309 1 1
2026-11-16 DEFA14A CURRENT REPORT 0001213900-26-120635 001-35890 261560694 34 23388
2026-11-16 8-K CURRENT REPORT 5.07,8.01 0001213900-26-120625 001-35890 261560607 34 241976 1 1
2026-11-13 8-K CURRENT REPORT 2.02,9.01 0001213900-26-119916 001-35890 261554188 34 339838 1 1
2026-11-13 10-Q QUARTERLY REPORT 0001213900-26-119910 001-35890 261554161 34 6362985 1 1
2026-11-12 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-26-118986 001-35890 261547688 34 298938 1 1
2026-11-10 8-K CURRENT REPORT 5.07 0001213900-26-118006 001-35890 261540260 34 245926 1 1
2026-11-06 8-K CURRENT REPORT 3.01 0001213900-26-116484 001-35890 261528791 34 247149 1 1
2026-11-03 3 xslF345X06/ownership.xml 0001213900-26-115343 3296
2026-11-02 4 OWNERSHIP DOCUMENT 0001213900-26-114957 6275
2026-11-02 3 OWNERSHIP DOCUMENT 0001213900-26-114956 4316
2026-11-02 ARS FORM ARS 0001213900-26-114919 001-35890 261512279 34 3759634
2026-10-30 8-K CURRENT REPORT 5.02 0001213900-26-114376 001-35890 261508012 34 240482 1 1
2026-10-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-112476 001-35890 261485959 34 4603249 1 1
2026-10-20 DEFA14A CURRENT REPORT 0001213900-26-111032 001-35890 261472788 34 27349
2026-10-20 8-K CURRENT REPORT 5.07,8.01 0001213900-26-111026 001-35890 261472771 34 246260 1 1
2026-10-19 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-26-110669 001-35890 261469041 34 284083 1 1
2026-10-16 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-110304 001-35890 261466721 34 2596878 1 1
2026-10-14 D xslFormDX01/primary_doc.xml 06b 0001213900-26-109190 021-601073 261458100 33 12289
2026-10-02 4 xslF345X06/ownership.xml 0001213900-26-106400 5905
2026-10-02 3 xslF345X06/ownership.xml 0001213900-26-106399 3231
2026-10-02 424B3 PROSPECTUS 0001213900-26-106362 333-299142 261436199 33 134232
2026-10-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003135 333-299142 261433340 33 1969
2026-09-28 8-K CURRENT REPORT 1.01,5.02,7.01,9.01 0001213900-26-104034 001-35890 261417250 34 408863 1 1
2026-09-25 S-3 REGISTRATION STATEMENT 0001213900-26-103526 333-299142 261410774 33 370763 1 1
2026-09-17 8-K 8-K 1.01,7.01,9.01 0001193125-26-394492 001-35890 261387650 34 425379 1 1
2026-09-16 DEFA14A DEFA14A 0001193125-26-393155 001-35890 261384223 34 23623
2026-09-16 8-K 8-K 5.07,8.01 0001193125-26-393151 001-35890 261384203 34 182559 1 1
2026-09-15 8-K 8-K 1.01,3.02,9.01 0001193125-26-391903 001-35890 261380848 34 826221 1 1
2026-09-01 424B3 424B3 0001193125-26-378588 333-298498 261351653 33 181146
2026-08-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002838 333-298498 261348386 33 1969
2026-08-27 CORRESP filename1.htm 0001193125-26-371259 6322
2026-08-27 UPLOAD filename1.pdf 0000000000-26-008466 333-298498 147048
2026-08-24 8-K 8-K 5.02 0001193125-26-363695 001-35890 261311184 34 177934 1 1
2026-08-21 S-1 S-1 0001193125-26-361240 333-298498 261305305 33 485617 1 1
2026-08-18 DEFA14A DEFA14A 0001193125-26-355565 001-35890 261291228 34 23351
2026-08-18 8-K 8-K 5.07,8.01 0001193125-26-355550 001-35890 261291117 34 182230 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349381 001-35890 261274226 34 8360589 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-349374 001-35890 261274191 34 462546 1 1
2026-08-13 8-K 8-K 1.01,3.02,9.01 0001193125-26-349334 001-35890 261274083 34 608045 1 1
2026-07-28 DEFA14A DEFA14A 0001193125-26-321197 001-35890 261212753 34 30294
2026-07-28 8-K 8-K 5.07,8.01 0001193125-26-321176 001-35890 261212716 34 181562 1 1
2026-07-22 8-K 8-K 1.01,7.01,9.01 0001193125-26-312391 001-35890 261193747 34 289887 1 1
2026-07-17 DEF 14A DEF 14A 0001140361-26-028823 001-35890 261184115 34 1520750
2026-07-08 424B3 424B3 0001193125-26-298528 333-297061 261162456 33 152313
2026-07-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002212 333-297061 261160694 33 1969
2026-07-07 PRE 14A PRE 14A 0001140361-26-027791 001-35890 261160255 34 1524967
2026-07-02 CORRESP filename1.htm 0001193125-26-294492 6099
2026-07-02 UPLOAD filename1.pdf 0000000000-26-006619 333-297061 146175
2026-06-26 S-3 S-3 0001193125-26-285430 333-297061 261128953 33 372218 1 1
2026-06-23 4 4 0001193125-26-279703 11082
2026-06-23 8-K 8-K 5.07 0001193125-26-278068 001-35890 261108675 34 179657 1 1
2026-06-23 D xslFormDX01/primary_doc.xml 06b 0001193125-26-278048 021-588192 261108654 33 9507
2026-06-17 4 4 0001193125-26-274545 5722
2026-06-17 3 3 0001193125-26-274538 3306
2026-06-08 3 3 0001193125-26-262648 3811
2026-06-08 4 4 0001193125-26-262257 5608
2026-06-08 DEF 14A DEF 14A 0001140361-26-024453 001-35890 261072633 34 1697081
2026-06-04 8-K 8-K 5.02,7.01,9.01 0001193125-26-257684 001-35890 261065830 34 218574 1 1
2026-06-02 8-K 8-K 1.01,3.02,9.01 0001193125-26-251994 001-35890 261053063 34 501513 1 1
2026-05-29 PRE 14A PRE 14A 0001140361-26-023347 001-35890 261045874 34 1592036
2026-05-29 8-K 8-K 5.02 0001193125-26-248648 001-35890 261045760 34 175643 1 1
2026-05-22 8-K 8-K 3.01 0001193125-26-237207 001-35890 261015152 34 188539 1 1
2026-05-22 8-K 8-K 5.02 0001193125-26-237150 001-35890 261014966 34 176218 1 1
2026-05-14 10-Q 10-Q 0001193125-26-224289 001-35890 26980254 34 7050421 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001193125-26-224156 001-35890 26979513 34 409777 1 1
2026-05-06 8-K 8-K 7.01,8.01,9.01 0001193125-26-207601 001-35890 26945851 34 7766918 1 1
2026-04-10 424B3 424B3 0001193125-26-150470 333-294843 26853370 33 121873
2026-04-10 424B3 424B3 0001193125-26-150469 333-294740 26853366 33 160268
2026-04-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001134 333-294843 26853027 33 1968
2026-04-08 CORRESP filename1.htm 0001193125-26-146348 7479
2026-04-07 UPLOAD filename1.pdf 0000000000-26-003497 333-294843 40280
2026-04-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001088 333-294740 26839471 33 1968
2026-04-03 D xslFormDX01/primary_doc.xml 06b 0001231919-26-000307 021-579044 26837697 33 10617
2026-04-02 4 xslF345X06/form4-04022026_050423.xml 0001947673-26-000002 5944
2026-04-02 4 xslF345X06/form4-04022026_050421.xml 0001871423-26-000002 5896
2026-04-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-140271 005-87213 26834245 34 25895
2026-04-02 S-3 S-3 0001193125-26-138652 333-294843 26830409 33 330874 1 1
2026-04-01 CORRESP filename1.htm 0001193125-26-138193 7229
2026-04-01 UPLOAD filename1.pdf 0000000000-26-003300 333-294740 40268
2026-03-31 S-8 POS S-8 POS 0001193125-26-133140 333-294732 26816672 33 44085
2026-03-30 S-3 S-3 0001193125-26-132096 333-294740 26814475 33 366636 1 1
2026-03-30 S-8 S-8 0001193125-26-132033 333-294732 26814311 33 205660 1 1
2026-03-30 10-K 10-K 0001193125-26-130490 001-35890 26810105 34 15007977 1 1
2026-03-30 8-K 8-K 2.02,9.01 0001193125-26-130480 001-35890 26810084 34 426411 1 1
2026-03-25 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001931356-26-000013 005-87213 26793663 34 14589
2026-03-25 4 xslF345X06/form4-03252026_090332.xml 0001931356-26-000011 6554
2026-03-23 8-K 8-K 1.01,3.02,9.01 0001193125-26-118618 001-35890 26779974 34 817922 1 1
2026-02-25 8-K 8-K 7.01,8.01,9.01 0001193125-26-068614 001-35890 26674274 34 223879 1 1
2026-02-11 8-K 8-K 7.01,9.01 0001193125-26-045543 001-35890 26618371 34 18522155 1 1
2026-02-10 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001931356-26-000009 005-87213 26617234 34 14033
2026-02-06 4 xslF345X05/form4-02062026_090210.xml 0001931356-26-000006 5740
2026-02-06 3 xslF345X02/form3-02062026_090250.xml 0001931356-26-000004 4338
2026-02-06 8-K 8-K 1.01,2.01,3.02,5.01,5.02,9.01 0001193125-26-041190 001-35890 26607759 34 609917 1 1
2026-01-28 4 xslF345X05/form4-01282026_040107.xml 0001871563-26-000002 5689
2026-01-28 4 xslF345X05/form4-01282026_040105.xml 0001321402-26-000003 5686
2026-01-28 4 xslF345X05/form4-01282026_040101.xml 0001214505-26-000003 5708
2026-01-28 4 xslF345X05/form4-01282026_040103.xml 0001127430-26-000002 5843
2026-01-28 8-K 8-K 3.03,5.02,5.07 0001193125-26-027203 001-35890 26572496 34 195364 1 1
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001535610-26-000017 005-87213 26545030 34 9457
2026-01-09 8-K 8-K 3.01 0001193125-26-008938 001-35890 26523247 34 174897 1 1
2025-12-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000019 333-292026 26500020 33 1968
2025-12-31 ARS ARS 0001140361-25-047055 001-35890 251617646 34 2012103
2025-12-31 DEF 14A DEF 14A 0001140361-25-047054 001-35890 251617633 34 7511483 1 1
2025-12-30 CORRESP filename1.htm 0001193125-25-336469 8636
2025-12-23 CORRESP filename1.htm 0001193125-25-330311 79422
2025-12-12 UPLOAD filename1.pdf 0000000000-25-011525 333-292026 44216
2025-12-09 S-1 S-1 0001193125-25-312887 333-292026 251559743 33 441481 1 1
2025-12-02 PRE 14A PRE 14A 0001140361-25-043939 001-35890 251542324 34 7527252 1 1
2025-11-26 8-K 8-K 3.02,8.01,9.01 0001193125-25-298604 001-35890 251524767 34 713074 1 1
2025-11-25 424B5 424B5 0001193125-25-294736 333-280918 251515514 33 538464
2025-11-19 DEFA14A DEFA14A 0001193125-25-287188 001-35890 251496872 34 567507
2025-11-19 8-K 8-K 1.01,3.02,5.02,8.01,9.01 0001193125-25-287163 001-35890 251496857 34 888868 1 1
2025-11-05 10-Q 10-Q 0001193125-25-265946 001-35890 251452058 34 7149997 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265937 001-35890 251452042 34 442717 1 1
2025-08-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-108261 005-87213 251213568 34 26033
2025-08-11 10-Q 10-Q 0000950170-25-106558 001-35890 251202147 34 7560522 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106544 001-35890 251202049 34 456520 1 1
2025-06-12 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-25-139899 001-35890 251042728 34 529536 1 1
2025-06-12 424B5 424B5 0001193125-25-139623 333-280918 251041780 33 579324
2025-06-11 8-K 8-K 8.01 0001193125-25-138802 001-35890 251038787 34 175431 1 1
2025-06-06 8-K 8-K 5.02 0001193125-25-137041 001-35890 251030594 34 178663 1 1
2025-05-13 10-Q 10-Q 0000950170-25-070441 001-35890 25940678 34 6435967 1 1
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-070416 001-35890 25940506 34 419026 1 1
2025-04-30 10-K/A 10-K/A 0001193125-25-107127 001-35890 25894908 34 838011 1 1
2025-04-28 8-K 8-K 8.01 0001193125-25-098817 001-35890 25876630 34 143511 1 1
2025-04-18 8-K 8-K 2.05 0001193125-25-085773 001-35890 25850586 34 183529 1 1
2025-04-09 8-K 8-K 1.02,7.01,9.01 0001193125-25-076938 001-35890 25825992 34 227730 1 1
2025-04-07 8-K 8-K 3.03,9.01 0001193125-25-073987 001-35890 25816392 34 201565 1 1
2025-03-27 S-8 S-8 0001193125-25-065616 333-286186 25780477 33 89420
2025-03-27 10-K 10-K 0000950170-25-046144 001-35890 25779978 34 12943072 1 1
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-046055 001-35890 25779297 34 418542 1 1
2025-02-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-018140 005-87213 25611184 34 24650
2025-02-06 424B5 424B5 0001193125-25-021851 333-280918 25598222 33 552967
2025-01-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000195 333-280918 25560756 33 1975
2025-01-24 CORRESP filename1.htm 0001193125-25-012246 7846
2025-01-24 S-3/A S-3/A 0001193125-25-012238 333-280918 25554633 33 172941
2025-01-06 4 xslF345X05/form4-01062025_050116.xml 0001415889-25-000807 5695
2025-01-06 4 xslF345X05/form4-01062025_050114.xml 0001415889-25-000806 5717
2025-01-06 4 xslF345X05/form4-01062025_050118.xml 0001415889-25-000808 5721
2025-01-06 4 xslF345X05/form4-01062025_050112.xml 0001415889-25-000805 5673
2024-12-31 8-K 8-K 3.01 0001193125-24-287170 001-35890 241592955 34 184346 1 1
2024-12-06 8-K 8-K 1.01,3.03,5.07,9.01 0001193125-24-272464 001-35890 241532480 34 207379 1 1
2024-11-12 DEF 14A DEF 14A 0001140361-24-046210 001-35890 241449190 34 1577720
2024-11-12 10-Q 10-Q 0000950170-24-125499 001-35890 241448757 34 6295522 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125444 001-35890 241448452 34 413160 1 1
2024-10-29 PRE 14A PRE 14A 0001140361-24-044533 001-35890 241405916 34 1573946
2024-10-10 8-A12B/A 8-A12B/A 0001193125-24-235607 001-35890 241363831 34 17364
2024-10-10 8-K 8-K 1.01,3.03,8.01,9.01 0001193125-24-235598 001-35890 241363819 34 245458 1 1
2024-08-13 144 xsl144X01/primary_doc.xml 0000950170-24-095769 001-35890 241198852 33 6290
2024-08-12 SC 13D/A SC 13D/A 0001193125-24-199144 005-87213 241198457 34 162839
2024-08-12 4 4 0000950170-24-095675 25537
2024-08-09 144 xsl144X01/primary_doc.xml 0001178937-24-000041 001-35890 241192305 33 5763
2024-08-08 10-Q 10-Q 0000950170-24-094124 001-35890 241189200 34 6089518 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-094102 001-35890 241189034 34 421589 1 1
2024-07-23 UPLOAD filename1.pdf 0000000000-24-008307 333-280918 40273
2024-07-19 S-3 S-3 0001193125-24-181673 333-280918 241128138 33 819853
2024-07-08 4 xslF345X05/form4-07082024_040701.xml 0001415889-24-019339 4999
2024-07-03 4 xslF345X05/form4-07032024_110739.xml 0001415889-24-019279 5018
2024-07-02 4 xslF345X05/form4-07022024_040706.xml 0001415889-24-018866 5027
2024-06-20 424B5 424B5 0001193125-24-164037 333-257990 241054215 33 1387139
2024-06-20 8-K 8-K 1.01,8.01,9.01 0001193125-24-164015 001-35890 241054148 34 515872 1 1
2024-06-14 4 xslF345X05/form4-06142024_060608.xml 0001415889-24-017012 5836
2024-06-14 4 xslF345X05/form4-06142024_060605.xml 0001415889-24-017011 5736
2024-06-14 4 xslF345X05/form4-06142024_060603.xml 0001415889-24-017010 5716
2024-06-14 4 xslF345X05/form4-06142024_060601.xml 0001415889-24-017009 5711
2024-06-14 8-K 8-K 5.07 0001193125-24-161685 001-35890 241045509 34 192028 1 1
2024-05-13 SC 13D/A SC 13D/A 0001193125-24-137304 005-87213 24939945 34 165607
2024-05-09 10-Q 10-Q 0000950170-24-057072 001-35890 24931196 34 5452883 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-057047 001-35890 24931121 34 378592 1 1
2024-04-23 ARS ARS 0001193125-24-106980 001-35890 24864868 34 4177985
2024-04-23 DEFA14A DEFA14A 0001193125-24-106971 001-35890 24864805 34 529890
2024-04-23 DEF 14A DEF 14A 0001193125-24-106959 001-35890 24864766 34 808707
2024-03-19 S-8 S-8 0001193125-24-071472 333-278071 24764826 33 84137
2024-03-19 10-K 10-K 0000950170-24-033555 001-35890 24763981 34 10876174 1 1
2024-03-19 8-K 8-K 2.02,9.01 0000950170-24-033464 001-35890 24763270 34 393192 1 1
2024-02-14 SC 13G/A tpst13ga.htm 0000935836-24-000223 005-87213 24641344 34 46803
2024-02-14 SC 13G/A rocksprings-tpst123123a2.htm 0001172661-24-001212 005-87213 24635961 34 110304
2024-02-09 SC 13G/A filing.txt 0000315066-24-001539 005-87213 24612619 34 8152
2024-02-08 SC 13D/A SC 13D/A 0001193125-24-028545 005-87213 24610411 34 164562
2024-01-05 4 FORM 4 SUBMISSION 0001209191-24-001040 9047
2024-01-05 4 FORM 4 SUBMISSION 0001209191-24-001038 9082
2024-01-05 4 FORM 4 SUBMISSION 0001209191-24-001036 5779
2024-01-05 4 FORM 4 SUBMISSION 0001209191-24-001035 5723
2023-11-17 S-8 POS S-8 POS 0001193125-23-279857 333-235515 231419481 33 71849
2023-11-17 S-8 POS S-8 POS 0001193125-23-279851 333-249993 231419464 33 71849
2023-11-17 S-8 POS S-8 POS 0001193125-23-279849 333-255261 231419458 33 71849
2023-11-17 S-8 POS S-8 POS 0001193125-23-279846 333-264943 231419449 33 71849
2023-11-17 S-8 POS S-8 POS 0001193125-23-279845 333-265718 231419444 33 71849
2023-11-17 S-8 S-8 0001193125-23-279836 333-275637 231419404 33 96140
2023-11-09 SC 13D/A SC 13D/A 0001193125-23-274644 005-87213 231393939 34 180771
2023-11-08 10-Q 10-Q 0000950170-23-061278 001-35890 231389340 34 6971229 1 1
2023-11-08 8-K 8-K 2.02,9.01 0000950170-23-061271 001-35890 231389280 34 501042 1 1
2023-11-02 144 xsl144X01/primary_doc.xml 0001971857-23-000783 001-35890 231372550 33 5330
2023-10-30 8-K 8-K 8.01 0001193125-23-265621 001-35890 231357096 34 142269 1 1
2023-10-13 4 FORM 4 SUBMISSION 0001209191-23-052783 5705
2023-10-13 4 FORM 4 SUBMISSION 0001209191-23-052782 5748
2023-10-13 4 FORM 4 SUBMISSION 0001209191-23-052781 5744
2023-10-13 4 FORM 4 SUBMISSION 0001209191-23-052780 5721
2023-10-12 424B5 424B5 0001193125-23-254553 333-257990 231321663 33 6717
2023-10-11 8-A12B 8-A12B 0001193125-23-253894 001-35890 231319463 34 15704
2023-10-11 8-K 8-K 1.01,3.03,5.03,8.01,9.01 0001193125-23-253882 001-35890 231319454 34 703792 1 1
2023-09-08 8-K 8-K 3.01 0001193125-23-231557 001-35890 231245472 34 144599 1 1
2023-09-07 8-K 8-K 5.02 0001193125-23-230659 001-35890 231242513 34 144146 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041429 001-35890 231160209 34 8171954 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041385 001-35890 231159965 34 500269 1 1
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038453 5632
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038448 5657
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038443 5757
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038440 5637
2023-06-16 8-K 8-K 5.02,5.07 0001193125-23-169021 001-35890 231021487 34 163311 1 1
2023-05-10 10-Q 10-Q 0000950170-23-020579 001-35890 23906862 34 6231945 1 1
2023-05-10 8-K 8-K 2.02,9.01 0000950170-23-020569 001-35890 23906796 34 454281 1 1
2023-05-01 ARS ARS 0001193125-23-130458 001-35890 23873871 34 1906256
2023-05-01 DEFA14A DEFA14A 0001193125-23-130422 001-35890 23873747 34 958760
2023-05-01 DEF 14A DEF 14A 0001193125-23-130398 001-35890 23873642 34 1080445
2023-04-28 8-K 8-K 8.01,9.01 0001193125-23-124510 001-35890 23860524 34 195001 1 1
2023-03-31 8-K 8-K 8.01 0001193125-23-088320 001-35890 23789032 34 144034 1 1
2023-03-22 10-K 10-K 0000950170-23-009237 001-35890 23753831 34 13234490 1 1
2023-03-22 8-K 8-K 2.02,9.01 0000950170-23-009236 001-35890 23753818 34 443311 1 1
2023-02-14 SC 13G/A rocksprings-tpst123122a1.htm 0001172661-23-001256 005-87213 23627577 34 110372
2023-02-14 SC 13G tempest13g.htm 0000935836-23-000230 005-87213 23625323 34 49367
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-002148 5666
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-002146 5636
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-002144 5620
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-002142 5645
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-002141 5683
2022-12-29 8-K 8-K 1.01,2.03,9.01 0001193125-22-314745 001-35890 221498901 34 253116 1 1
2022-11-08 10-Q 10-Q 0001544227-22-000006 001-35890 221367433 34 5519463 1 1
2022-11-08 8-K 8-K 2.02,9.01 0001544227-22-000004 001-35890 221367422 34 483678 1 1
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052025 5702
2022-10-04 3 FORM 3 SUBMISSION 0001209191-22-052024 9250
2022-09-23 8-K 8-K 5.02 0001193125-22-250135 001-35890 221262397 34 145589 1 1
2022-08-15 10-Q 10-Q 0001628280-22-022788 001-35890 221162462 34 5492935 1 1
2022-08-15 8-K 8-K 2.02,9.01 0001628280-22-022786 001-35890 221162448 34 698282 1 1
2022-06-22 4 FORM 4 - 0001179110-22-003402 5609
2022-06-22 4 FORM 4 - 0001179110-22-003401 5661
2022-06-22 4 FORM 4 - 0001179110-22-003400 5682
2022-06-22 4 FORM 4 - 0001179110-22-003399 5649
2022-06-22 4 FORM 4 - 0001179110-22-003398 5672
2022-06-22 4 FORM 4 - 0001179110-22-003383 5610
2022-06-22 4 FORM 4 - 0001179110-22-003380 5520
2022-06-22 4 FORM 4 - 0001179110-22-003378 5546
2022-06-22 4 FORM 4 - 0001179110-22-003377 5518
2022-06-22 4 FORM 4 - 0001179110-22-003376 5513
2022-06-21 S-8 S-8 0001193125-22-177081 333-265718 221026108 33 88948
2022-06-21 8-K 8-K 5.02,5.07,9.01 0001193125-22-177053 001-35890 221026052 34 487449 1 1
2022-06-09 8-K 8-K 8.01,9.01 0001193125-22-170659 001-35890 221004963 34 181017 1 1
2022-05-27 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-27 09:00:00 9999999995-22-001621 333-264989 22980207 33 1938
2022-05-27 424B3 424B3 0001193125-22-161796 333-264989 22972791 33 220201
2022-05-26 8-K 8-K 8.01,9.01 0001193125-22-161149 001-35890 22971203 34 181383 1 1
2022-05-26 DEFA14A DEFA14A 0001193125-22-160984 001-35890 22969954 34 106786
2022-05-24 CORRESP filename1.htm 0001193125-22-158494 7381
2022-05-18 UPLOAD filename1.pdf 0000000000-22-005499 40427
2022-05-16 S-3 S-3 0001193125-22-151971 333-264989 22930645 33 313411
2022-05-13 S-8 S-8 0001193125-22-150094 333-264943 22922877 33 80274
2022-05-13 10-Q 10-Q 0001628280-22-014231 001-35890 22920308 34 5373342 1 1
2022-05-13 8-K 8-K 2.02,9.01 0001628280-22-014229 001-35890 22920307 34 656693 1 1
2022-05-11 D xslFormDX01/primary_doc.xml 06b 0001209191-22-028252 021-445321 22913465 33 11586
2022-05-09 SC 13D SC 13D 0001193125-22-145151 005-87213 22906319 34 192894
2022-05-09 DEFA14A DEFA14A 0001193125-22-144339 001-35890 22903316 34 780570
2022-05-09 DEFA14A DEFA14A 0001193125-22-144331 001-35890 22903300 34 419533
2022-05-03 4 FORM 4 SUBMISSION 0000899243-22-016387 9582
2022-05-03 4 FORM 4 SUBMISSION 0000899243-22-016383 22745
2022-05-03 3 FORM 3 SUBMISSION 0000899243-22-016348 9057
2022-05-02 DEFA14A DEFA14A 0001193125-22-136754 001-35890 22881973 34 639015
2022-05-02 DEF 14A DEF 14A 0001193125-22-136738 001-35890 22881905 34 1335047
2022-05-02 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-22-135401 001-35890 22879476 34 737846 1 1
2022-04-22 PRE 14A PRE 14A 0001193125-22-115067 001-35890 22845426 34 1275417
2022-04-14 424B5 424B5 0001193125-22-105720 333-257990 22828147 33 8080
2022-04-01 10-K/A 10-K/A 0001193125-22-092417 001-35890 22795533 34 358119 1 1
2022-03-29 10-K 10-K 0001628280-22-007717 001-35890 22781713 34 12856512 1 1
2022-03-29 8-K 8-K 2.02,9.01 0001628280-22-007714 001-35890 22781534 34 335578 1 1
2022-02-17 SC 13G SCHEDULE 13G 0001213900-22-008260 005-87213 22648361 34 68677
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041892 005-87213 22632978 34 84095
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-021236 005-87213 22624728 34 74655
2022-02-14 SC 13G/A TEMPEST THERAPEUTICS, INC. 0001104659-22-021142 005-87213 22624610 34 139866
2022-02-11 SC 13G SC 13G 0001193125-22-034847 005-87213 22616069 34 131768
2022-01-11 4 FORM 4 SUBMISSION 0001209191-22-002963 4803
2022-01-10 4 FORM 4 SUBMISSION 0001209191-22-002753 4834
2022-01-10 3 FORM 3 0001567619-22-000944 9239
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002253 5599
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002251 5651
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002249 5672
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002247 5659
2022-01-06 4 FORM 4 SUBMISSION 0001209191-22-002245 5639
2022-01-03 SC 13G efc21-001_sc13g.htm 0000905148-22-000002 005-87213 22502244 34 106689
2021-12-23 8-K 8-K 5.02 0001628280-21-025555 001-35890 211517218 34 172943 1 1
2021-11-10 10-Q 10-Q 0001628280-21-022803 001-35890 211396593 34 6402920 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001628280-21-022785 001-35890 211396359 34 372621 1 1
2021-09-30 8-K/A 8-K/A 5.02 0001193125-21-287569 001-35890 211294092 34 154996 1 1
2021-09-24 8-K 8-K 5.03,9.01 0001193125-21-281694 001-35890 211275356 34 289553 1 1
2021-09-23 4 FORM 4 SUBMISSION 0001209191-21-057511 5613
2021-09-20 4/A FORM 4/A - 0001179110-21-008869 5833
2021-09-20 4/A FORM 4/A - 0001179110-21-008868 5898
2021-09-20 4/A FORM 4/A - 0001179110-21-008867 5840
2021-09-20 4/A FORM 4/A - 0001179110-21-008866 6494
2021-08-12 10-Q 10-Q 0001193125-21-244745 001-35890 211167972 34 6163645 1 1
2021-08-12 8-K 8-K 2.02,5.02,9.01 0001193125-21-244725 001-35890 211167911 34 234608 1 1
2021-08-10 4 FORM 4 - 0001179110-21-008097 5572
2021-08-10 3 FORM 3 - 0001179110-21-008096 6895
2021-07-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-07-23 16:00:00 9999999995-21-002903 333-257990 211112228 33 1939
2021-07-23 8-K 8-K 8.01,9.01 0001193125-21-223143 001-35890 211111654 34 233668
2021-07-23 424B5 424B5 0001193125-21-223072 333-257990 211111316 33 436325
2021-07-22 CORRESP filename1.htm 0001193125-21-221705 6474
2021-07-21 UPLOAD filename1.pdf 0000000000-21-008998 40436
2021-07-16 S-3 S-3 0001193125-21-217581 333-257990 211096260 33 746340
2021-07-16 8-K 8-K 8.01,9.01 0001193125-21-217458 001-35890 211095795 34 1953542
2021-07-15 SC 13G/A rocksprings-tpst062821a1.htm 0001172661-21-001532 005-87213 211092989 34 111330
2021-07-14 4 FORM 4 0001567619-21-013380 5621
2021-07-14 3 FORM 3 0001567619-21-013378 12228
2021-07-12 8-K 8-K 5.02 0001193125-21-212534 001-35890 211084546 34 20478
2021-07-08 SC 13G rocksprings-tpst062821.htm 0001172661-21-001463 005-87213 211080447 34 110121
2021-07-07 8-K 8-K 5.02,9.01 0001193125-21-209988 001-35890 211078141 34 194052
2021-07-07 S-8 S-8 0001193125-21-208968 333-257727 211075897 33 286386
2021-07-06 3 FORM 3 0001567619-21-013031 18310
2021-07-06 4 FORM 4 0001140361-21-023544 5882
2021-07-06 4 FORM 4 0001140361-21-023542 5285
2021-07-06 4 FORM 4 0001140361-21-023540 16275
2021-07-06 4 FORM 4 0001140361-21-023538 5324
2021-07-06 3 FORM 3 0001140361-21-023537 12218
2021-07-06 SC 13G filing.txt 0001385495-21-000006 005-87213 211072898 34 7824
2021-07-01 8-K/A 8-K/A 4.01,9.01 0001193125-21-206427 001-35890 211066530 34 518205
2021-06-30 4 FORM 4 0001140361-21-022931 13153
2021-06-30 3 FORM 3 0001140361-21-022925 14549
2021-06-29 4 FORM 4 0001140361-21-022786 6555
2021-06-29 4 FORM 4 0001140361-21-022784 15283
2021-06-29 4 FORM 4 0001140361-21-022785 10649
2021-06-29 4 FORM 4 0001140361-21-022783 15124
2021-06-29 4 FORM 4 0001140361-21-022782 10642
2021-06-29 4 FORM 4 0001140361-21-022781 12031
2021-06-29 3 FORM 3 0001140361-21-022780 12427
2021-06-29 3 FORM 3 0001140361-21-022775 12596
2021-06-29 3 FORM 3 0001140361-21-022774 12314
2021-06-29 3 FORM 3 0001140361-21-022772 13071
2021-06-29 3 FORM 3 0001140361-21-022771 12611
2021-06-29 3 FORM 3 0001140361-21-022770 13136
2021-06-28 8-K 8-K 1.01,2.01,2.03,3.03,5.01,5.02,5.03,7.01,9.01 0001193125-21-201157 001-35890 211050148 34 89441
2021-06-23 8-K 8-K 5.07,8.01,9.01 0001193125-21-196512 001-35890 211037023 34 66437
2021-06-11 8-K 8-K 8.01 0001193125-21-189024 001-35890 211012343 34 62628
2021-06-11 425 8-K 0001193125-21-189025 001-35890 211012321 34 63227
2021-05-13 10-Q 10-Q 0001544227-21-000029 001-35890 21917175 34 3709430 1 1
2021-05-11 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2021-05-11 16:00:00 9999999995-21-001882 333-255198 21913287 33 1786
2021-05-11 424B3 424B3 0001193125-21-157780 333-255198 21912510 33 7994602
2021-05-10 S-4/A S-4/A 0001193125-21-156414 333-255198 21908389 33 8587539
2021-05-07 CORRESP filename1.htm 0001193125-21-155148 7402
2021-05-04 S-4/A S-4/A 0001193125-21-148605 333-255198 21885716 33 18237598 1 1
2021-04-29 10-K/A 10-K/A 0001544227-21-000026 001-35890 21870589 34 679482 1 1
2021-04-16 UPLOAD filename1.pdf 0000000000-21-004635 40292
2021-04-15 S-8 S-8 0001544227-21-000021 333-255261 21829130 33 120135
2021-04-13 S-4 S-4 0001193125-21-114415 333-255198 21822738 33 8082847
2021-04-13 SC 13D/A NEW ENTERPRISE ASSOCIATES 15, L.P. / MILLENDO THERAPEUTICS, INC. -- SCHEDULE 13D 0001072613-21-000364 005-87213 21822208 34 345103
2021-04-07 SC 13G SC 13G 0001193125-21-109044 005-87213 21813080 34 115959
2021-03-29 10-K 10-K 0001544227-21-000018 001-35890 21779478 34 5913217 1 1
2021-03-29 8-K FORM 8-K 1.01,8.01,9.01 0001104659-21-042768 001-35890 21779451 34 3895072
2021-03-29 425 FORM 8-K 0001104659-21-042769 001-35890 21779450 34 3895556
2021-03-19 4 FORM 4 0001544227-21-000013 5768
2021-03-16 SC 13G SC 13G 0001104659-21-036489 005-87213 21743174 34 187537
2021-03-02 4 FORM 4 0001544227-21-000011 5800
2021-03-02 4 FORM 4 0001544227-21-000010 5874
2021-02-16 SC 13G/A greatpoint-mlnd123120a2.htm 0001172661-21-000715 005-87213 21638543 34 111788
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-022714 005-87213 21632295 34 68916
2021-02-09 3 FORM 3 0001544227-21-000007 13919
2021-01-28 8-K 8-K 2.05,5.02,9.01 0001544227-21-000005 001-35890 21562074 34 130502
2021-01-05 8-K FORM 8-K 8.01,9.01 0001104659-21-000639 001-35890 21504082 34 41985
2020-11-10 S-8 S-8 0001544227-20-000048 333-249993 201299658 33 135488
2020-11-09 10-Q 10-Q 0001544227-20-000045 001-35890 201296045 34 4450725 1 1
2020-09-24 8-K 8-K 8.01,9.01 0001544227-20-000042 001-35890 201193585 34 242302 1 1
2020-08-10 10-Q 10-Q 0001544227-20-000039 001-35890 201087028 34 4977170 1 1
2020-07-30 SC 13D/A SC 13D/A 0001104659-20-088216 005-87213 201059717 34 289624
2020-06-23 8-K FORM 8-K 5.02,5.07,8.01,9.01 0001104659-20-075873 001-35890 20980368 34 1830052
2020-06-23 4 FORM 4 0001544227-20-000035 5506
2020-06-23 4 FORM 4 0001544227-20-000034 5478
2020-06-23 4 FORM 4 0001544227-20-000033 5520
2020-06-23 4 FORM 4 0001544227-20-000032 5494
2020-06-23 4 FORM 4 0001544227-20-000031 5489
2020-06-23 4 FORM 4 0001544227-20-000030 5472
2020-06-23 4 FORM 4 0001544227-20-000029 5453
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032489 5804
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032488 5736
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032487 5716
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032486 5757
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032485 5712
2020-05-08 10-Q 10-Q 0001544227-20-000014 001-35890 20858684 34 4313784 1 1
2020-04-24 DEFA14A DEFA14A 0001544227-20-000010 001-35890 20814586 34 1310415
2020-04-24 DEF 14A DEF 14A 0001544227-20-000008 001-35890 20814571 34 1701092
2020-04-08 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001193125-20-101340 005-87213 20782097 34 169954
2020-04-06 8-K FORM 8-K 2.05,8.01,9.01 0001104659-20-043387 001-35890 20775723 34 911174
2020-03-31 4 FORM 4 SUBMISSION 0001209191-20-021851 5620
2020-03-17 SC 13G/A AMENDMENT NO. 1 TO FORM SC 13G 0001387131-20-002923 005-87213 20719401 34 69104
2020-03-11 10-K 10-K 0001544227-20-000004 001-35890 20703862 34 9225173 1 1
2020-03-04 424B5 424B5 0001047469-20-001193 333-230749 20685828 33 59014
2020-03-04 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-028925 001-35890 20685775 34 243661
2020-02-14 SC 13G/A greatpoint-mlnd123119a2.htm 0001172661-20-000845 005-87213 20620263 34 112534
2020-02-11 4 FORM 4 SUBMISSION 0001209191-20-008370 5635
2020-02-11 3 FORM 3 SUBMISSION 0001209191-20-008367 6746
2020-02-10 8-K FORM 8-K 8.01,9.01 0001104659-20-012871 001-35890 20589721 34 62335
2020-02-04 4 FORM 4 SUBMISSION 0001209191-20-006367 5597
2020-02-04 4 FORM 4 SUBMISSION 0001209191-20-006361 5601
2020-02-04 4 FORM 4 SUBMISSION 0001209191-20-006355 5621

Latest XBRL company facts

One latest value per concept from companyfacts (442 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 20.00M 2026-11-13 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
dei EntityPublicFloat Entity Public Float USD 30.10M 2025-06-30 2025 FY 10-K 2026-03-30 0001193125-26-130490
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 744,795 2025-01-01 2025-12-31 DEF 14A 2026-10-26 0001213900-26-112476
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.04M 2025-01-01 2025-12-31 DEF 14A 2026-10-26 0001213900-26-112476
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.52M 2025-01-01 2025-12-31 DEF 14A 2026-10-26 0001213900-26-112476
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.30M 2025-01-01 2025-12-31 DEF 14A 2026-10-26 0001213900-26-112476
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 19.2 2025-01-01 2025-12-31 DEF 14A 2026-10-26 0001213900-26-112476
ffd NetFeeAmt NetFeeAmt USD 1,132.33 2026-09-24 S-3 2026-09-25 0001213900-26-103526
ffd TtlFeeAmt TtlFeeAmt USD 1,132.33 2026-09-24 S-3 2026-09-25 0001213900-26-103526
ffd TtlOfferingAmt TtlOfferingAmt USD 8.20M 2026-09-24 S-3 2026-09-25 0001213900-26-103526
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-24 S-3 2026-09-25 0001213900-26-103526
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-24 S-3 2026-09-25 0001213900-26-103526
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 775,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 3.28M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 980,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.01M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 300,000 2018-06-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -89,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 277.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -6.42M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.24M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 54,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 2.25M 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-14 0001104659-12-057721
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 762,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 163,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 52,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 18.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 9,780 2019-02-28 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 200,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap Assets Assets USD 8.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AssetsCurrent Assets, Current USD 1.61M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 100,000 2018-06-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 300,000 2018-02-28 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 200,000 2017-07-31 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 53.63M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 0 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 9,000 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 53.64M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 10.40M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 5.00M 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 46.35M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2018-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 49.57M 2013-09-30 2013 Q3 10-Q 2013-11-13 0001104659-13-084216
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 9,000 2013-09-30 2013 Q3 10-Q 2013-11-13 0001104659-13-084216
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 6,000 2013-09-30 2013 Q3 10-Q 2013-11-13 0001104659-13-084216
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions security 5 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year security 1 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year security 5 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets USD 20,000 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 524,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 884,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 33.32M 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 897,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 6.41M 2014-12-31 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 27.30M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 897,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -6.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -20.09M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061278
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 8.90M 2013-03-31 2013 Q1 10-Q 2013-05-15 0001104659-13-041862
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.805 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 6.78M 2026-02-03 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 17,125 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 403,109 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 136 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 16.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 16.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CommonStockValue Common Stock, Value, Issued USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap CommonUnitIssuanceValue Common Unit, Issuance Value USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -26.61M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001544227-22-000006
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -20.61M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap CostOfRevenue Cost of Revenue USD 210,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 56,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 67,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 11,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 499,504 2018-12-07 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap DebtCurrent Debt, Current USD 199,000 2019-06-30 2019 Q2 10-Q 2019-08-12 0001558370-19-007932
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.06 2018-08-01 2018-08-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 400,000 2018-08-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 8.60M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions security 4 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 4 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 100,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount USD 800,000 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046144
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 200,000 2019-09-30 2019 Q3 10-Q 2019-11-13 0001558370-19-010887
us-gaap DeferredRentCredit Deferred Rent Credit USD 334,000 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 353,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 1.25M 2016-09-30 2016 Q3 10-Q 2016-11-03 0001544227-16-000016
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.24M 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 185.70M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 152.07M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 534.50M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 501.90M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 98,000 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 3.94M 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 21.20M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.58M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 352,000 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 687,000 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 183.50M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 19,000 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap DefinedContributionPlanAdministrativeExpenses Defined Contribution Plan, Administrative Expense USD 200,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 300,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 44,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap Depreciation Depreciation USD 176,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 633,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -7.49 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.194 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.117 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.005 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.022 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.009 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001544227-16-000008
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -6,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001544227-22-000006
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 322,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 4.20M 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 5.20M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap EquityMethodInvestmentAggregateCost Equity Method Investment, Aggregate Cost USD 1.50M 2013-12-31 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2013-12-31 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap EquityMethodInvestments Equity Method Investments USD 140,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) USD 500,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001104659-15-036822
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2016-12-31 2016 FY 10-K 2017-03-02 0001544227-17-000002
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2016-12-31 2016 FY 10-K 2017-03-02 0001544227-17-000002
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 63.00M 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 10,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 174,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -98,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-13 0001558370-19-010887
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 321,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -9,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 2.20M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -20.75M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -6,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD -1.02M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 300,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap IncomeTaxesPaid Income Taxes Paid USD 152,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0000950170-23-061278
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 300,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 5.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -5.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 90,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 343,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -2.96M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046144
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.14M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046144
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 478,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.64M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 993,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 219,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD -59,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -883,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -285,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 350,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap InsuranceSettlementsReceivable Insurance Settlements Receivable USD 450,000 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap InterestAndDividendsPayableCurrent Interest and Dividends Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap InterestAndOtherIncome Interest and Other Income USD 286,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001544227-22-000006
us-gaap InterestExpense Interest Expense USD 740,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-094124
us-gaap InterestExpenseDebt Interest Expense, Debt USD 200,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 207,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 643,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -1,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 192,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap InterestReceivable Interest Receivable USD 260,000 2021-06-30 2021 Q2 10-Q 2021-08-12 0001193125-21-244745
us-gaap InventoryWriteDown Inventory Write-down USD 400,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-02 0001544227-17-000002
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 44,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001104659-15-036822
us-gaap InvestmentIncomeNet Investment Income, Net USD 752,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 82,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 800,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap LegalFees Legal Fees USD 300,000 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.07 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 16.90M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 6.41M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.61M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.99M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.93M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.86M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.10M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.21M 2022-03-31 2022 Q1 10-Q 2022-05-13 0001628280-22-014231
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.16M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap Liabilities Liabilities USD 10.59M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 450,000 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap LoansPayable Loans Payable USD 0 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap LongTermDebt Long-term Debt USD 4.20M 2025-03-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070441
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046144
us-gaap MarketableSecurities Marketable Securities USD 439,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 668,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 16.21M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 5.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 124.79M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001104659-15-036822
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 17.89M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001104659-15-036822
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -12.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -14.39M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001104659-15-036822
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -36.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -50.98M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap NetRentableArea Net Rentable Area sqft 6,000 2012-05-01 2012 FY 10-K 2013-02-25 0001047469-13-001570
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 Noncash or Part Noncash Acquisition, Investments Acquired USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001544227-16-000008
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 9.79M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -776,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap NotesPayableCurrent Notes Payable, Current USD 3.50M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001544227-22-000006
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 0 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OperatingExpenses Operating Expenses USD 21.59M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -35.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 200,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 11.74M 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 5.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OperatingLeasePayments Operating Lease, Payments USD 352,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001558370-19-010887
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.64M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.68M 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.80M 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 347,000 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 851,000 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 828,000 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 805,000 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 45,000 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 100,000 2015-09-30 2015 Q3 10-Q 2015-11-05 0001544227-15-000004
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 200,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 37,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OtherAssetsCurrent Other Assets, Current USD 417,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 81,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OtherCommitment Other Commitment USD 8.90M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001544227-22-000006
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -89,000 2021-07-01 2021-09-30 2022 Q3 10-Q 2022-11-08 0001544227-22-000006
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest USD 10,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-13 0001558370-19-010887
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -31.89M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001558370-19-010887
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001193125-21-244745
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 24,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OtherGeneralExpense Other General Expense USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -6,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD 174,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 30,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 28,000 2012-09-30 2012 Q3 10-Q 2012-11-13 0001104659-12-077250
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-13 0001104659-13-084216
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.84M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 197,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001544227-20-000045
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 95,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 808,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 100,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 33.49M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap PreferredStockDividendsPerShareCashPaid Preferred Stock, Dividends, Per Share, Cash Paid USD/shares 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap PreferredStockDividendsPerShareDeclared Preferred Stock, Dividends Per Share, Declared USD/shares 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125499
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 712,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 295,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap PrepaidInsurance Prepaid Insurance USD 211,000 2012-09-30 2012 Q3 10-Q 2012-11-13 0001104659-12-077250
us-gaap PrepaidRent Prepaid Rent USD 29,000 2012-09-30 2012 Q3 10-Q 2012-11-13 0001104659-12-077250
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates Proceeds from Divestiture of Businesses and Interests in Affiliates USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001544227-18-000007
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 34.99M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 6.00M 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 15.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 99.41M 2021-01-01 2021-06-25 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 3.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 154,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-02 0001544227-17-000002
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 10.38M 2011-04-05 2014-03-31 2014 Q1 10-Q 2014-05-08 0001104659-14-036131
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 8.00M 2018-08-01 2018-08-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 70.76M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 200,000 2018-09-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 8,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 438,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 108,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 47,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 86,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -36.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 200,000 2017-07-01 2017-07-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 429,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap PurchaseObligation Purchase Obligation USD 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 86.71M 2021-06-25 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 38,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap RepaymentsOfDebt Repayments of Debt USD 6.43M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 202,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 19.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 2.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 63.84M 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap RestrictedCash Restricted Cash USD 789,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 32.71M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-02 0001544227-17-000002
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 791,000 2018-03-31 2018 Q1 10-Q 2018-05-03 0001544227-18-000004
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 450,000 2022-12-31 2023 Q3 10-Q 2023-11-08 0000950170-23-061278
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -117,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 12.90M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employees 21 2025-04-01 2025-04-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent pure 0.5 2017-12-31 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestructuringCharges Restructuring Charges USD 3.64M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestructuringCosts Restructuring Costs USD 6.90M 2016-12-21 2017-03-31 2017 Q1 10-Q 2017-05-09 0001544227-17-000007
us-gaap RestructuringReserve Restructuring Reserve USD 47,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 100,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 60,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001544227-17-000007
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -278.94M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 203,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap Revenues Revenues USD 67,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001544227-18-000004
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 10.66M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap SaleOfStockPercentageOfOwnershipBeforeTransaction Sale of Stock, Percentage of Ownership before Transaction pure 0.05 2026-08-13 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.15 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap SecurityDeposit Security Deposit USD 400,000 2015-05-31 2015 Q3 10-Q 2015-11-05 0001544227-15-000004
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 11.04M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap SeveranceCosts1 Severance Costs USD 3.20M 2025-06-05 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.26M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 266,108 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.7 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.35 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-224289
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.01 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.5 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 469,125 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 221,999 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 57.68 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 29,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 72,049 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 3.25M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 405,879 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 522,541 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.36 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 136 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 566,766 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) shares 416,005 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 23.91 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 566,766 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 23.91 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 10,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.52M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 11.28 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 1.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 16.4 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 40.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap SharePrice Share Price USD/shares 4.71 2020-12-31 2020 FY 10-K 2021-03-29 0001544227-21-000018
us-gaap ShortTermInvestments Short-term Investments USD 14.43M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -1.83M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -1.83M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2.023 2012-03-28 2012-03-29 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap StockIssued1 Stock Issued USD 49,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 6.76M 2018-12-01 2018-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 5.37M 2021-06-24 2021-06-25 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349381
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 19.93M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 30.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 86.71M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 18.00M 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001193125-21-244745
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 170,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 334,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 6.49M 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001558370-19-002660
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-02 0001544227-17-000002
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046144
us-gaap SubleaseIncome Sublease Income USD 87,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001544227-21-000029
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 2.20M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001544227-18-000009
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 13.60M 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD -101,000 2011-04-05 2014-03-31 2014 Q1 10-Q 2014-05-08 0001104659-14-036131
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2021-12-31 2021 FY 10-K 2022-03-29 0001628280-22-007717
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 100.19M 2021-06-25 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 135.94M 2021-06-25 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 114.69M 2021-06-25 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 114.69M 2021-06-25 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap TransferToInvestments Transfer to Investments USD 1.50M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-16 0001047469-15-002286
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 5.41M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 167,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009237
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-130490
us-gaap VariableInterestEntityOwnershipPercentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage pure 0.5 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001544227-18-000002
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 14.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 2.74M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001628280-21-022803
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0000950170-24-033555
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 14.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 14.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119910
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-11 0001544227-20-000004

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →